All In MedTech

Device Trial Radar · NCT01715571

Assessment of Penile Vibratory Stimulation Using the Viberect in Men With Mild-Moderate ED

Clinical and Physiological Assessment of Noninvasive Penile Afferent Vibratory Stimulation of Both Surfaces of the Penis Using the Viberect® Device in Men With Mild to Moderate ED

Last checked: Nov 19, 2026Latest source record: Jun 23, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

11

Actual

Start

Mar 1, 2013

Primary completion

Jun 1, 2020

Study completion Jul 1, 2020

Sponsor

Lead sponsor
Johns Hopkins UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 29, 2012

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Male only, from 30 years, up to 70 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The primary objective of this study is to assess the safety, acceptability, and satisfaction of penile vibratory stimulation in treatment of erectile dysfunction (ED). The secondary objective is to demonstrate subjective physiological response (erection, rigidity, orgasm) after four weeks of frequent device use and the satisfaction of penile erection and sexual intercourse with partner.

Conditions

  • Organic Erectile Dysfunction

Interventions

  • ViberectDevice

    Men will be asked to perform vibratory stimulation of the penis in the privacy of their home, while focused on sexual thoughts for approximately 7-10 minutes (depending on erectile response) for 3 times a week, one day apart, throughout the four week period. Men can perform the stimulation once daily, as long as each session is more than 24 hours apart. Men will record device use and intercourse attempts after device use in a diary.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Assessment of Ease/Acceptability of Use of the Viberect as Assessed by EDITS QuestionnaireTime frame: baseline
  2. Acceptability of Use of the Viberect as Assessed by TSSTime frame: Baseline
  3. Assessment of Ease/Acceptability of Use of the Viberect as Assessed by EDITS QuestionnaireTime frame: Week 4

1 more outcomes with a free account

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Johns Hopkins Hospital

    Baltimore, Maryland

  • Frederick Urology Specialists

    Frederick, Maryland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.